ARID1A and thrombocytosis disease: Key predictors included ARID1A loss, elevated CA125, thrombocytosis, and p16 expression among key predictors of relapse; while shared high-risk features across models were advanced stage, deep myometrial invasion, elevated CA125, and positive cytology.